Objective: SYM 2081 ((2S,4R)-4-methylglutamic acid), an agonist and functional antagonist of the kainite receptor, has shown a neuroprotective effect in neurodegenerative diseases in adults but little is known concerning perinatal hypoxic-ischemic encephalopathy. This study is designed to evaluate whether SYM 2081 has preventive mechanisms via anti-apoptosis to gain further insight into neuroprotective roles of SYM 2081. Methods: In an in vivo animal model, the left carotid artery was ligated in 7-day-old Sprague-Dawley rat pups. The pups were divided into six groups: normoxia (N), hypoxia (8% O 2 , 92% N 2 ) (H), H with sham operation, H with operation (HO), HO treated with vehicle and HO treated with SYM 2081. In an in vitro model, the cultured embryonic cortical neuronal cells were divided into three groups: normoxia (95% air, 5% CO 2 ), hypoxia (94% N 2 , 5% CO 2 ) (Hc), and Hc treated with SYM 2081 before a hypoxic insult. Apoptosis was assessed using western blots and real-time polymerase chain reaction with Bcl-2, Bax, and caspase-3 antibodies and mRNAs. Results: In both in vitro and in vivo studies, Bcl-2 expression increased, whereas expressions of Bax, caspase-3, and the ratio of Bax/Bcl-2 were reduced with SYM 2081 treatment resulting in improved cell survival. Conclusion: This study showed that SYM 2081 exerts a neuroprotective effect against hypoxic-ischemic injury through modulating apoptotic signaling pathways.
Introduction
Hypoxic-ischemic encephalopathy (HIE) is a leading cause of major mortality and morbidity in the neonatal period. 1, 2 Hypothermia is now used as an established therapy, but many newborns with moderate to severe HIE still suffer from severe neurodevelopmen tal pro blems. 2, 3 Thus, continuous efforts have been conducted to benefit from adjuvant therapy in combination with hypothermia treatment. 1 Understanding of the cellular sig naling network that regulates programmed cell death and identification of the genes can provide insights for therapies targeted at inhibition of cell death after neonatal HIE.
Apoptosis is one important mechanism controlling the neuronal damage after hypoxicischemic (HI) injury. 4 Caspase-related signaling pathways can lead to apoptosis and are likely involved in neurodegeneration. 5, 6 Apoptosis is regulated by a balance between the pro-and anti-apoptotic proteins. 5, 7, 8 Expression of several apoptosis-associated proteins is induced by brain damage. 9 The classic pathways associated with caspase activation, each with distinct molecular mechanisms, are the caspase-9-dependent intrinsic and the caspase-8-dependent extrinsic pathways. 10 The caspase-3 pathway is common to both final intrinsic and extrinsic pathways for apoptosis and thus has been used as a marker for assessing apoptosis. 11 The Bcl family members are also activated following neonatal HI injury and are closely related to the Several reports demonstrated the associations between gluta mate receptors and excitotoxicity. 13, 14 Kainate receptor (KAR) has also been known to contribute to excitotoxicity with N-methyl-D-aspartate (NMDA) or α-amino-3-hydroxy-5methyl-4-isoxazolepropionic acid (AMPA) receptors. 15 Although KAR has various functions such as regulation of glutamate release, inhibition of GABA release, and induction of calcium current in the presence of an agonist, it has been shown that its various responses depend on fac tors such as subtype, editing, location, maturation, and agonist concentration. 16, 17 Research on KAR has been less frequent than for other glutamamergic receptors.
Our previous study showed the neuroprotective effect of SYM 2081 ((2S,4R)-4-methylglutamic acid) through modula ting KAR expression in neonatal rat brain. 18 This raised our interest in investigating the possible cellular mechanisms of SYM 2081 effects on gene expression of apoptosis. Therefore, this study is designed to evaluate whether SYM 2081 has pre ventive mechanisms via anti-apoptosis using western blots and real-time PCR with Bcl-2, Bax, and caspase-3 antibodies and mRNAs to gain further insight into neuroprotective roles of SYM 2081.
Methods

Materials
We purchased SYM 2081 from Tocris (Bristol, UK). Primary antibodies used in this study included the following: Bcl-2 
Animal model and drug administration
This study was carried out under the approved animal use guidelines and protocol of the Catholic University of Daegu.
All rats were supplied with food and water ad libitum and were housed at 23±1℃ on a 12:12-h light:dark cycle. The rat pups were reared with their respective mothers. Experiments were performed on postnatal seven-day-old Sprague-Dawley (SD) rat pups in this research. To induce perinatal HI brain injury, a modification of the Levine preparation was used as a model for perinatal HI brain injury as previously described. 19 Briefly, the left carotid artery (LCCA) was isolated via midline incision at the longitudinal plane under isoflurane anesthesia and underwent double ligation permanently with 5-0 surgical silk. The total period of procedure never exceeded 5 minutes. Following one hour of recovery with the dam and feeding, the pups were placed in an airtight polypropylene container (295×230×84 mm, 3.9 L volume; Lock & Lock, Yongin, Korea), which were submerged in a 37℃ water bath and exposed to hypoxia (a mixture of 8% O 2 and 92% N 2 ) for 2 hours. The oxygen le vel was monitored using an oxygen monitor (Hudson RCI, Temecula, CA, USA). After this hypoxic exposure, the pups were returned to their dams for the indicated time. As the test agent, SYM 2081 was dissolved in phosphate-buffered saline (PBS) and injected intraperitoneally (i.p.) at a dose of 10 mg/kg at 30 minutes before the hypoxic exposure. We used the dose of a previous study that showed neuroprotective effects. 18 Over the course of the experiment, a total of 55 litters were under study from which six rats died. The animals were randomly divided into six groups (n=7-10/group). The animals were randomly allocated into six treatment groups: normoxia (N, n=8) was not exposed to hypoxia; hypoxia (H, n=8) was 
Embryonic cortical neuronal cell culture of rats
RNA extraction and real-time PCR
Tissues and cells were homogenized in TRIzol reagent (Invitrogen Corporation, Carlsbad, CA, USA) before a 5 minutes incubation at room temperature followed by a chloroform treatment (200 μL) for dissociation of the nucleoprotein complexes.
The sample tubes were shaken by hand for 15 seconds, and incubated at room temperature for 2 minutes. The upper aqueous RNA phase was collected following centrifu gation (12,000 x g for 15 minutes at 4℃). The aqueous phase was then transferred into a fresh tube and precipitated into a gel-like pellet with 500 μL isopropyl alcohol by incubating for 10 minutes at room temperature and then centrifuging (12,000 x g for 15 minutes at 4℃).
After removal of the supernatant, the RNA pellet was washed once with 1 mL 75% ethanol by centri fugation (7,500 x g for 5 minutes at 4℃). The RNA pellet was air-dried for 10 minutes before redissolving the RNA in 100 μL RNase-free water and incubating for 10 minutes at 60℃. The amount and purity of ex- cor tical neuronal cells were prepared from SD rat embryos pregnant for 19 days using methods similar to those previously de scribed. 20 The fetal pups were washed in 100% ethanol and
Hanks' balanced salt solution (HBSS) (GibcoBRL, Grand Island, NY, USA). Briefly, cerebral cortices were separated and dissected at 37℃ in HBSS containing 1 mM sodium pyruvate and 10 mM (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.4). The dissected brain cortical tissues were then placed in 2 mL of trypsin and incubated at 37℃ in a water bath for 1 minute.
After washing with 10 mL of HBSS, the cell suspension was centrifuged at 1,000 rpm at 25℃ for 5 minutes and the pellets washed with HBSS (without phenol red 
Brain extraction and protein isolation
Rat pups were sacrificed on the seventh day after the hypoxic insult (on post-natal day 14). Brain samples were rapidly removed from the left cerebral hemispheres and then homoge- 
Western blotting
Approximately 50 μg of the total protein was denatured in a www.e-kjp.org 
Statistics analysis
Data analysis was performed using SPSS version 22 statisti cal 
Results
Expressions of Bcl-2, Bax, and caspase-3 antibodies by western blots in neonatal HI brain injury (in vivo)
To determine whether SYM 2081 reduced apoptosis against a hypoxic injury, western blot was used to differentiate and measure the levels of apoptosis-related proteins. Western blot analysis showed that Bcl-2 antibody decreased significantly in the HO and HV compared to N, H, and HS groups, but increased in the HM compared to HO and HV groups (P<0.05) (Fig. 1A) .
The expressions of Bax and caspase-3 antibodies and the ratio of Bax/Bcl-2 increased significantly in the HO and HV compared to N, H, and HS groups, but decreased in the HM compared to HO and HV groups (P<0.05) ( Fig. 1B-1D ).
Expressions of Bcl-2, Bax, and caspase-3 mRNAs by realtime PCR in neonatal HI brain injury (in vivo)
Real-time PCR of mRNA levels of Bcl-2, Bax, and caspase-3 was used to estimate the expression of apoptosis-related genes.
The expression of Bcl-2 mRNA decreased significantly in the HO and HV compared to the N, H, and HS groups, but increased in the HM compared to HV group (P<0.05) ( Fig. 2A) . The expressions of Bax and caspase-3 mRNA and the ratio of Bax/ Bcl-2 increased significantly in the HO and HV compared to N, H, and HS groups, and decreased in the HM compared to HO and HV groups (P<0.05) ( Fig. 2B-2D ). The expression of Bax was more prominent than that of Bcl-2, resulting in a striking difference in the ratio of Bax/Bcl-2 compared with the HO and HM groups in the in vivo study.
Expressions of Bcl-2, Bax, and caspase-3 antibodies by western blots in embryonic cortical neuronal cell culture (in vitro)
Western blot analysis showed that Bcl-2 antibody decreased significantly in the Hc compared to Nc group, but it increased in the HMc compared to Hc group (P<0.05) (Fig. 3A, 3B ). The www.e-kjp.org Perinatology Bax/Bcl-2 showed greater in the Hc than Nc group and lesser in the HMc than Hc group (P<0.05) (Fig. 3A, 3C-3E ). 
expressions of Bax and caspase-3 antibodies and the ratio of
Expressions of
Discussion
Cell death during normal brain development occurs to re move unnecessary cells and select appropriate cells for survi val and shows various cell death types such as necrosis, apop tosis, and autophagy. 4 Cell death may have a significant role in neuronal injury in various pathological conditions such as neonatal HIE, and their magnitude depend on insult-severity, time, and matura tion, and be region-specific. 7 Cell fate is not determined randomly or chaotically; rather cell death is strictly regulated by crosstalk between necrotic, autophagic, and apop totic pathways. 22 Although the pathologic features of HIE are predominantly necrosis, 23 expression of apoptosis-related proteins is also increased in HIE. 4, 24 Although apoptosis is also considered the key mechanisms of neuronal damage in neonatal HI animal mo- Perinatology dels, 24, 25 the pathologic features in HIE still show necrotic cell death. 23 The neonatal brain has a proclivity to apoptosis, but energy failure after HI insult may interrupt apoptotic processes, resulting in necrosis-like pathology. Thus, agents that inhibit apoptosis in injury with mainly necrotic pathology could show neuroprotective effect. 26 Indeed each cell death is closely regulated by cross-talk, and depends on species, cell type, involved brain lesion, 27 degree of immaturity, severity, energy failure, and gender. 4, 28 Moreover, genetic expression that nor mally confers apoptosis inhibition and neuroprotection, at times can result in apoptosis exacerbation, depending on the degree of cellular energy failure; a severe cellular energy fail ure can result in greater necrosis or autophagy, albeit with an inhibition of apoptosis and the timing of that inhibition, over the course of the injury. 28, 29 The use of agents that inhibit apoptosis during severe cellular energy failure, may instead exacerbate the injury. 30 Ne vertheless, various antiapoptotic agents have been tried for neuroprotection because apoptosis is considered as one of the important pathogenic mechanisms involved in neo natal HIE injury.
SYM 2081 is known to be the most potent methylglutamate analog and has a methyl group located at position 4. 31, 32 This methyl group position is associated with KAR affinity. 32 www.e-kjp.org Perinatology calcium current, thereby changing predominant cell death type and leading to reduced neuronal damage. 31 As mentioned previously, presynaptic KAR regulates glutamate release. 35 Since GluK1 is a pharmacologically dominant subtype in heteromeric KARs, presynaptic GluK1 inhibition by SYM 2081 may reduce the release of glutamate by desensitization. 36 An increase in intracellular calcium should be accompanied by glutamate release facilitated by KAR. 35 The expression of apoptosis-regulating proteins such as Bax and caspase-3 was increased and Bcl-2/Bax ratio was decreased as the intensity of apoptosis progresses. 25, 37 Indeed, Bcl proteins and caspases are crucial proteins involved in apoptotic cell pathways and are useful marker for assessing apoptosis. 37 In this study, proapoptotic markers such as caspase, BAX, and the Bax/Bcl-2 ratio increased after hypoxia ex posure following LCAA ligation, consistent with other studies. 6 Notably, changes in expression of Bax in the in vivo study are worthy of notice. Bax is a member of the Bcl family that in creases cytochrome C in response to apoptotic stimuli leading to apoptosis. 8 The expression of Bax can increase after HIE, and its inhibition could lead to neuroprotection effect. 38 The expression
of Bax changes to a subcellular distribution without little change in Bcl-2 level after insult. 39 In this study, the changes in Bax ex pression were much more prominent than of Bcl-2 in the HO group, resulting in greater changes in Bax/Bcl-2 ratio. Further more, with SYM 2081 treatment, the Bax expression was much more suppressed than the normoxia level, showing the pro-and anti-apoptotic balance directed toward inhibiting apoptosis.
Thus, SYM 2081 could inhibit apoptosis and amelio rate neuronal injury through Bax inhibition while also increasing Bcl-2 and reducing caspase-3 expres sion. 40 In previous our work, 18 we found that SYM 2081 reduced the volume loss after HI injury and this study showed that SYM 2081 also have neuroprotective effects through modulating apoptosis process.
The limitation of this study is results are not applicable to clinical practice because the study design didn't involve pretreating subjects before a HI injury because of the practically 
